APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epidermal Growth Factor Receptor (EGFR) Inhibitor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Growth and Trends Forecast to 2032

22 December 202587 pages

Choose your research edition.

Industry ResearchEpidermal Growth Factor Receptor (EGFR) Inhibitor Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Epidermal Growth Factor Receptor (EGFR) Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Epidermal Growth Factor Receptor (EGFR) Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epidermal Growth Factor Receptor (EGFR) Inhibitor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Epidermal Growth Factor Receptor (EGFR) Inhibitor market include Novartis AG, Eli Lilly and Co., Amgen Inc., AstraZeneca Plc and F. Hoffmann-La Roche Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Epidermal Growth Factor Receptor (EGFR) Inhibitor market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Epidermal Growth Factor Receptor (EGFR) Inhibitor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Company

Novartis AG

Eli Lilly and Co.

Amgen Inc.

AstraZeneca Plc

F. Hoffmann-La Roche Ltd.

Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Type

Colorectal Cancer

Lung Cancer

Breast Cancer

Others

Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Application

Clinic

Hospital

Research Institutes and Research Institutions

Other

Epidermal Growth Factor Receptor (EGFR) Inhibitor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epidermal Growth Factor Receptor (EGFR) Inhibitor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epidermal Growth Factor Receptor (EGFR) Inhibitor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Epidermal Growth Factor Receptor (EGFR) Inhibitor companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2021-2026) Table 4. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2027-2032) Table 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Type (2021-2026) Table 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share Forecasted by Type (2027-2032) Table 11. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2021-2026) Table 24. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share Forecasted by Application (2027-2032) Table 26. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Trends Table 37. Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Drivers Table 38. Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Opportunities and Challenges Table 39. Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Restraints Table 40. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Company (2021-2026) Table 42. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Company Headquarters & Area Served Table 44. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Company, Product Type & Application Table 45. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis AG Company Information Table 49. Novartis AG Business Overview Table 50. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 52. Novartis AG Recent Development Table 53. Eli Lilly and Co. Company Information Table 54. Eli Lilly and Co. Business Overview Table 55. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 57. Eli Lilly and Co. Recent Development Table 58. Amgen Inc. Company Information Table 59. Amgen Inc. Business Overview Table 60. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 62. Amgen Inc. Recent Development Table 63. AstraZeneca Plc Company Information Table 64. AstraZeneca Plc Business Overview Table 65. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 67. AstraZeneca Plc Recent Development Table 68. F. Hoffmann-La Roche Ltd. Company Information Table 69. F. Hoffmann-La Roche Ltd. Business Overview Table 70. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio Table 72. F. Hoffmann-La Roche Ltd. Recent Development Table 73. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 74. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 75. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2026) Table 76. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 77. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share Forecast by Country (2027-2032) Table 78. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 80. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2026) Table 81. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share Forecast by Country (2027-2032) Table 83. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 85. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2026) Table 86. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share Forecast by Country (2027-2032) Table 88. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 90. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2026) Table 91. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share Forecast by Country (2027-2032) Table 93. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026) & (US$ Million) Table 95. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2026) Table 96. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share Forecast by Country (2027-2032) Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Image Figure 3. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032) & (US$ Million) Figure 5. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region: 2025 VS 2032 Figure 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2021-2032) Figure 7. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Colorectal Cancer Image Figure 13. Global Colorectal Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Lung Cancer Image Figure 15. Global Lung Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Breast Cancer Image Figure 17. Global Breast Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type 2025 VS 2032 Figure 22. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Type (2021-2032) Figure 23. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Type (2021-2032) Figure 25. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Type (2021-2032) Figure 27. Clinic Image Figure 28. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Hospital Image Figure 30. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Research Institutes and Research Institutions Image Figure 32. Global Research Institutes and Research Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application 2025 VS 2032 Figure 37. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2021-2032) Figure 38. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2021-2032) Figure 40. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032) Figure 47. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032) Figure 50. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032) Figure 53. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032) Figure 56. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Colorectal Cancer
  • Lung Cancer
  • Breast Cancer
  • Others
Applications
  • Clinic
  • Hospital
  • Research Institutes and Research Institutions
  • Other
Companies covered
  • Novartis AG
  • Eli Lilly and Co.
  • Amgen Inc.
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2021-2032)
  5. 1.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2021-2026)
  6. 1.4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2027-2032)
  7. 1.5 Key Regions Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2021-2032)
  8. 1.5.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (2021-2032)
2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Colorectal Cancer
  3. 2.1.2 Lung Cancer
  4. 2.1.3 Breast Cancer
  5. 2.1.4 Others
  6. 2.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
  7. 2.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions
  11. 2.3.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Type (2021-2026)
3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinic
  3. 3.1.2 Hospital
  4. 3.1.3 Research Institutes and Research Institutions
  5. 3.1.4 Other
  6. 3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
  7. 3.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Regions
  11. 3.3.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Trends
  2. 4.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Drivers
  3. 4.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Opportunities and Challenges
  4. 4.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (2021-2026)
  2. 5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Key Company Headquarters & Area Served
  4. 5.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Company, Product Type & Application
  5. 5.5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Epidermal Growth Factor Receptor (EGFR) Inhibitor Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Eli Lilly and Co.
  8. 6.2.1 Eli Lilly and Co. Company Information
  9. 6.2.2 Eli Lilly and Co. Business Overview
  10. 6.2.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  12. 6.2.5 Eli Lilly and Co. Recent Developments
  13. 6.3 Amgen Inc.
  14. 6.3.1 Amgen Inc. Company Information
  15. 6.3.2 Amgen Inc. Business Overview
  16. 6.3.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  18. 6.3.5 Amgen Inc. Recent Developments
  19. 6.4 AstraZeneca Plc
  20. 6.4.1 AstraZeneca Plc Company Information
  21. 6.4.2 AstraZeneca Plc Business Overview
  22. 6.4.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  24. 6.4.5 AstraZeneca Plc Recent Developments
  25. 6.5 F. Hoffmann-La Roche Ltd.
  26. 6.5.1 F. Hoffmann-La Roche Ltd. Company Information
  27. 6.5.2 F. Hoffmann-La Roche Ltd. Business Overview
  28. 6.5.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
7 North America
  1. 7.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026)
  3. 7.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026)
  3. 8.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026)
  3. 10.3 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst